These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 29187877)

  • 21. miR-4521-FAM129A axial regulation on ccRCC progression through TIMP-1/MMP2/MMP9 and MDM2/p53/Bcl2/Bax pathways.
    Feng X; Yan N; Sun W; Zheng S; Jiang S; Wang J; Guo C; Hao L; Tian Y; Liu S; Sun MZ
    Cell Death Discov; 2019; 5():89. PubMed ID: 31016032
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LncRNA, NEAT1 is a prognosis biomarker and regulates cancer progression via epithelial-mesenchymal transition in clear cell renal cell carcinoma.
    Ning L; Li Z; Wei D; Chen H; Yang C
    Cancer Biomark; 2017; 19(1):75-83. PubMed ID: 28269753
    [TBL] [Abstract][Full Text] [Related]  

  • 23. KRT8 upregulation promotes tumor metastasis and is predictive of a poor prognosis in clear cell renal cell carcinoma.
    Tan HS; Jiang WH; He Y; Wang DS; Wu ZJ; Wu DS; Gao L; Bao Y; Shi JZ; Liu B; Ma LJ; Wang LH
    Oncotarget; 2017 Sep; 8(44):76189-76203. PubMed ID: 29100303
    [TBL] [Abstract][Full Text] [Related]  

  • 24. EZH2 Expression is increased in BAP1-mutant renal clear cell carcinoma and is related to poor prognosis.
    Sun C; Zhao C; Li S; Wang J; Zhou Q; Sun J; Ding Q; Liu M; Ding G
    J Cancer; 2018; 9(20):3787-3796. PubMed ID: 30405850
    [No Abstract]   [Full Text] [Related]  

  • 25. Down-regulation of CD74 inhibits growth and invasion in clear cell renal cell carcinoma through HIF-1α pathway.
    Ji SQ; Su XL; Cheng WL; Zhang HJ; Zhao YQ; Han ZX
    Urol Oncol; 2014 Feb; 32(2):153-61. PubMed ID: 23273913
    [TBL] [Abstract][Full Text] [Related]  

  • 26. ΑB-crystallin in clear cell renal cell carcinoma: tumor progression and prognostic significance.
    Ho PY; Chueh SC; Chiou SH; Wang SM; Lin WC; Lee IL; Yang HY; Peng HC; Lai MK
    Urol Oncol; 2013 Oct; 31(7):1367-77. PubMed ID: 22417627
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Low expressions of EHD2 and E-cadherin correlate with a poor prognosis for clear cell renal cell carcinoma].
    Ye M; Fan G; Zhu S; Han W; Xie Y
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2019 Aug; 44(8):864-870. PubMed ID: 31570672
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cytoskeleton-associated membrane protein 4 is upregulated in tumor tissues and is associated with clinicopathological characteristics and prognosis in hepatocellular carcinoma.
    Chen ZY; Wang T; Gan X; Chen SH; He YT; Wang YQ; Zhang KH
    Oncol Lett; 2020 Jun; 19(6):3889-3898. PubMed ID: 32382336
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Low NR3C2 levels correlate with aggressive features and poor prognosis in non-distant metastatic clear-cell renal cell carcinoma.
    Zhao Z; Zhang M; Duan X; Deng T; Qiu H; Zeng G
    J Cell Physiol; 2018 Oct; 233(10):6825-6838. PubMed ID: 29693713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of the miR-25-IMPA2 axis promotes metastatic progression in clear cell renal cell carcinoma.
    Lin YF; Chou JL; Chang JS; Chiu IJ; Chiu HW; Lin YF
    EBioMedicine; 2019 Jul; 45():220-230. PubMed ID: 31202813
    [TBL] [Abstract][Full Text] [Related]  

  • 31. High-level S100A6 promotes metastasis and predicts the outcome of T1-T2 stage in clear cell renal cell carcinoma.
    Lyu X; Li H; Ma X; Li X; Gao Y; Ni D; Shen D; Gu L; Wang B; Zhang Y; Zhang X
    Cell Biochem Biophys; 2015 Jan; 71(1):279-90. PubMed ID: 25120023
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Comparison of clinicopathological parameters with FoxM1 expression in renal cell carcinoma.
    Kocarslan S; Guldur ME; Ekinci T; Ciftci H; Ozardali HI
    J Cancer Res Ther; 2014; 10(4):1076-81. PubMed ID: 25579557
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long noncoding RNA
    Duan J; Ma X; Shi J; Xuan Y; Wang H; Li P; Zhang Y; Fan Y; Gong H; Ma X; Pang Y; Wang L; Yan Y; Zhang X
    Onco Targets Ther; 2019; 12():4729-4740. PubMed ID: 31417274
    [No Abstract]   [Full Text] [Related]  

  • 34. MicroRNA-185 inhibits cell proliferation and induces cell apoptosis by targeting VEGFA directly in von Hippel-Lindau-inactivated clear cell renal cell carcinoma.
    Ma X; Shen D; Li H; Zhang Y; Lv X; Huang Q; Gao Y; Li X; Gu L; Xiu S; Bao X; Duan J; Zhang X
    Urol Oncol; 2015 Apr; 33(4):169.e1-11. PubMed ID: 25700976
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Overexpression of low density lipoprotein receptor-related protein 1 (LRP1) is associated with worsened prognosis and decreased cancer immunity in clear-cell renal cell carcinoma.
    Feng C; Ding G; Ding Q; Wen H
    Biochem Biophys Res Commun; 2018 Sep; 503(3):1537-1543. PubMed ID: 30033103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. LSD1 inhibition suppresses the growth of clear cell renal cell carcinoma
    Zhu L; Wang J; Kong W; Huang J; Dong B; Huang Y; Xue W; Zhang J
    Acta Pharm Sin B; 2019 Mar; 9(2):324-334. PubMed ID: 30972280
    [TBL] [Abstract][Full Text] [Related]  

  • 37. miRNA‑205‑5p functions as a tumor suppressor by negatively regulating VEGFA and PI3K/Akt/mTOR signaling in renal carcinoma cells.
    Huang J; Wang X; Wen G; Ren Y
    Oncol Rep; 2019 Nov; 42(5):1677-1688. PubMed ID: 31545453
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Follistatin-like protein 1 plays a tumor suppressor role in clear-cell renal cell carcinoma.
    Liu Y; Tan X; Liu W; Chen X; Hou X; Shen D; Ding Y; Yin J; Wang L; Zhang H; Yu Y; Hou J; Thompson TC; Cao G
    Chin J Cancer; 2018 Jan; 37(1):2. PubMed ID: 29357946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant DNA methyltransferase 1 expression in clear cell renal cell carcinoma development and progression.
    Li M; Wang Y; Song Y; Bu R; Yin B; Fei X; Guo Q; Wu B
    Chin J Cancer Res; 2014 Aug; 26(4):371-81. PubMed ID: 25232208
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activation of the Dickkopf1-CKAP4 pathway is associated with poor prognosis of esophageal cancer and anti-CKAP4 antibody may be a new therapeutic drug.
    Shinno N; Kimura H; Sada R; Takiguchi S; Mori M; Fumoto K; Doki Y; Kikuchi A
    Oncogene; 2018 Jun; 37(26):3471-3484. PubMed ID: 29563607
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.